UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.10106-10107

2022

Volltextzugriff (PDF)

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

British journal of haematology, 2021-05, Vol.193 (4), p.750-760

2021

Volltextzugriff (PDF)

Upfront autologous stem cell transplantation (ASCT) versus carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation with K maintenance in transplant-eligible, newly diagnosed (NDTE) multiple myeloma (MM)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8000-8000

2021

Volltextzugriff (PDF)

COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial

British journal of haematology, 2021-01, Vol.192 (1), p.e14-e16

2021

Volltextzugriff (PDF)

P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S255-S256

2023

Volltextzugriff (PDF)

P-228: ASCT does not benefit patients who are MRD negative following induction therapy: updated results from the Phase 2 Cardamon study

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S160-S161

2022

Volltextzugriff (PDF)

P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON study

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S81-S82

2022

Volltextzugriff (PDF)

OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myeloma

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S11-S12

2022

Volltextzugriff (PDF)

OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S2-S3

2021

Volltextzugriff (PDF)

Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer

Journal of thoracic oncology, 2015-04, Vol.10 (4), p.611-618

2015

Volltextzugriff (PDF)

Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis

Analytical chemistry (Washington), 2015-11, Vol.87 (21), p.10942-10949

2015

Volltextzugriff (PDF)

New loci and coding variants confer risk for age-related macular degeneration in East Asians

Nature communications, 2015-01, Vol.6 (1), p.6063-6063, Article 6063

2015

Volltextzugriff (PDF)

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study

The Lancet (British edition), 2021-09, Vol.398 (10306), p.1147-1156

2021

Volltextzugriff (PDF)

PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing

Nature immunology, 2018-09, Vol.19 (9), p.942-953

2018

Volltextzugriff (PDF)

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3339-3351, Article 3339

2023

Volltextzugriff (PDF)

Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope

Nature (London), 2023-11, Vol.623 (7986), p.387-396

2023

Volltextzugriff (PDF)

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Cochrane database of systematic reviews, 2015-01, Vol.1 (1), p.CD008170-CD008170

2015

Volltextzugriff (PDF)

Site recognition and substrate screens for PKN family proteins

Biochemical journal, 2011-09, Vol.438 (3), p.535-543

2011

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

KollektionProQuest Dissertations & Theses A&I

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(51)
Tagungsberichte
(2)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(20)
Humans
(15)
Female
(6)
Male
(6)
Middle Aged
(6)
Physical Sciences
(5)
Technology
(5)
Animals
(4)
Chemistry
(4)
Genomics
(4)
Materials Science
(4)
Materials Science, Multidisciplinary
(4)
Biological And Medical Sciences
(3)
Chemical Sciences
(3)
Endocrinology & Metabolism
(3)
Hematology
(3)
Material Chemistry
(3)
Mice
(3)
Oncology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple Myeloma

Impact of Autologous Stem Cell Transplant (ASCT) Versus Consolidation on Health-Related Quality of Life (HRQoL) for Patients with Multiple Myeloma Receiving Carfilzomib Maintenance: Results from the Cardamon Trial

Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

PET-CT for Assessment of Multiple Myeloma Disease Burden and Metabolic Response before and after Carfilzomib-Based Induction, Consolidation and Carfilzomib Maintenance Therapy: Data from the UK NCRI Cardamon Study

Upfront Autologous Stem Cell Transplantation (ASCT) Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Consolidation in Transplant-Eligible, Newly Diagnosed (NDTE) Multiple Myeloma (MM): Results of the Cardamon Study According to Cytogenetic Risk

Upfront autologous stem cell transplantation (ASCT) versus carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation with K maintenance in transplant-eligible, newly diagnosed (NDTE) multiple myeloma (MM)

COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial

P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON study

Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial

Efficacy and Safety of Carfilzomib at 56mg/m2 with Cyclophosphamide and Dexamethasone (K56Cd) in Newly Diagnosed Multiple Myeloma Patients Followed By ASCT or K56Cd Consolidation: Initial Results of the Phase 2 Cardamon Study

P-228: ASCT does not benefit patients who are MRD negative following induction therapy: updated results from the Phase 2 Cardamon study

P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON study

OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myeloma

OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)

Upfront Autologous Stem Cell Transplantation (ASCT) vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Consolidation with K Maintenance in Transplant-Eligible, Newly Diagnosed (NDTE) Multiple Myeloma (MM): Results of the Phase 2 Non-Inferiority Cardamon Study

Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer

Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis

New loci and coding variants confer risk for age-related macular degeneration in East Asians

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study

PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Site recognition and substrate screens for PKN family proteins

Aktive Filter

Suchergebnisse filtern